酵素結合免疫吸着測定法（Elisa）試験の世界市場

酵素結合免疫吸着測定法（Elisa）試験の世界市場は2030年までに14億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に7億9,900万米ドルと推定される酵素結合免疫吸着測定法（Elisa）試験の世界市場は、2022年から2030年にかけてCAGR 7.7％で成長し、2030年には14億米ドルの改定規模に達すると予測されます。本レポートで分析したセグメントの1つであるサンドイッチELISAは、CAGR8%を記録し、分析期間終了時には7億860万米ドルに達すると予測されます。パンデミック後の回復が進んでいることを考慮し、間接法ELISA分野の成長は、今後8年間のCAGRが6.5%に修正されました。

米国市場は2億4,170万米ドル、中国はCAGR7.1%の成長を予測

米国の酵素結合免疫吸着測定法（Elisa）試験市場は、2022年に2億4,170万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてCAGR7.1%で推移し、2030年には2億4,800万米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ7.2％と6.1％の成長が予測されています。欧州では、ドイツがCAGR約6.2%で成長すると予測されています。

調査対象企業の例

• Abbexa
• Abcam
• Abelisa
• Abnova
• Agilent Technologies Inc.
• American Laboratory Products Company（ALPCO）
• BD Biosciences
• Bhat Bio-tech
• BioMerieux
• Bio-Rad Laboratories, Inc.
• Biorbyt
• Calbiotech
• Cayman Chemicals
• Crystal Chem
• Diagenics
• Eagle Biosciences
• Life Technologies Corporation
• Ortho-Clinical Diagnostics, Inc.
• R & D Systems Inc.
• Thermo Fisher Scientific. Inc.
• ZEUS Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• 世界のその他の地域

第4章 競合

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market to Reach $1.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Enzyme-linked Immunosorbent Assay (Elisa) Testing estimated at US$799 Million in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at aCAGR of 7.7% over the period 2022-2030. Sandwich ELISA, one of the segments analyzed in the report, is projected to record 8% CAGR and reach US$708.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Indirect ELISA segment is readjusted to a revised 6.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $241.7 Million, While China is Forecast to Grow at 7.1% CAGR

The Enzyme-linked Immunosorbent Assay (Elisa) Testing market in the U.S. is estimated at US$241.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$248 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 22 Featured) -

• Abbexa
• Abcam
• Abelisa
• Abnova
• Agilent Technologies Inc.
• American Laboratory Products Company (ALPCO)
• BD Biosciences
• Bhat Bio-tech
• BioMerieux
• Bio-Rad Laboratories, Inc.
• Biorbyt
• Calbiotech
• Cayman Chemicals
• Crystal Chem
• Diagenics
• Eagle Biosciences
• Life Technologies Corporation
• Ortho-Clinical Diagnostics, Inc.
• R & D Systems Inc.
• Thermo Fisher Scientific. Inc.
• ZEUS Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 10: World Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 13: World 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Sandwich ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Sandwich ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 16: World 16-Year Perspective for Sandwich ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Indirect ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Indirect ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 19: World 16-Year Perspective for Indirect ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Multiple & Portable ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Multiple & Portable ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 22: World 16-Year Perspective for Multiple & Portable ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• JAPAN
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• CHINA
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 46: China 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 47: China Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 49: China 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• EUROPE
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• FRANCE
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • TABLE 59: France Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 61: France 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 62: France Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 64: France 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• GERMANY
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• ITALY
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• UNITED KINGDOM
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • TABLE 77: UK Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 80: UK Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• REST OF EUROPE
  • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 84: Rest of Europe Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 85: Rest of Europe 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• ASIA-PACIFIC
  • Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 90: Asia-Pacific Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 91: Asia-Pacific 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030
• REST OF WORLD
  • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 96: Rest of World Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 97: Rest of World 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Research Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Enzyme-linked Immunosorbent Assay (Elisa) Testing by Type - Percentage Breakdown of Value Sales for Sandwich ELISA, Indirect ELISA, Multiple & Portable ELISA and Other Types for the Years 2014, 2023 & 2030

IV. COMPETITION